Ed Libby, MD

Associate Professor, Division of Medical Oncology
University of Washington
Associate Member
Clinical Research Division
Medical Oncologists, Hematologic Malignancies
Seattle Cancer Care Alliance

Education:

University of Texas Health Sciences Center, 1984, M.D.
University of Texas, 1979, B.S. (Chemistry)

Research Focus:

Multiple Myeloma
Amyloidosis
Waldenstrom’s macroglobulinemia
Lymphoma

Clinical Expertise:

Multiple myeloma
Plasma cell leukemia
Amyloidosis
Waldenstrom’s macroglobulinemia
Plasmacytoma
POEMS Syndrome
MGUS and smoldering multiple myeloma
Lymphoma

Current Studies:

RV-FOL-GELARC-0683C (RELEVANCE-7636)
Funding Source: Celgene Corporation             
A Phase 3 Open-Label Randomized Study to Compare the Efficacy and Safety of Rituximab plus Lenalidomide (CC-5013) versus Rituximab plus Chemotherapy Followed by Rituximab in Subjects with Previously Untreated Follicular Lymphoma.



Additional Links & Information

Related Labs & Projects

View all labs & projects >

Contact Information

Phone
(206) 288-1453
Fax
(206) 288-6817
Email
Additional contact

Mail Stop: G3200